CI

At a glance

ClinicalIndex Comparison Record
Phase 2Recruiting· 93 target
Drug / intervention
Therapeutic Interventiondrug
Likely dose
Not stated in record
Key inclusion· 5
  • ✓Clinically suspected or histologically confirmed solid or hematological malignancy with genetic testing completed or planned
  • ✓Failed first-line therapy (refractory) or no curative therapy options
  • ✓Measurable or non-measurable disease allowed
  • ✓Age 18 years or older
Key exclusion· 5
  • ✕Chemotherapy or radiotherapy within 3 weeks prior (6 weeks for nitrosoureas or mitomycin C)
  • ✕Unrecovered adverse events from prior therapy administered >3 weeks earlier
  • ✕Uncontrolled intercurrent illness including active infection, symptomatic heart failure, unstable angina, cardiac arrhythmia, or psychiatric illness limiting compliance
  • ✕Pregnancy

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03089554
NCT03089554Phase 2RecruitingOn Track
Long Recruiting
CompareCT.gov

Integration of Precision Medicine Into Cancer Therapeutics, Part 2: A Therapeutic Phase 2 Sub-study Evaluating Genomic Testing in Human Cancer and Outcomes of Targeted Therapies Recommended by an Institutional Multidisciplinary Molecular Tumor Board in Patients With Poor Prognosis Cancer

Rachel Miller·interventional·Posted Mar 24, 2017·Updated May 27, 2026

In Brief

A Phase 2 clinical trial evaluating Therapeutic Intervention for Cancer. Currently recruiting, targeting 93 participants across 1 site.

Detailed Summary

This is a substudy (Part 2) of a larger two-part clinical trial including both observational and therapeutic (interventional) cohorts to assess the progression free survival ratio of patients treated with a targeted therapy based on genomic analysis results and recommendation by the Markey Cancer Center Molecular Tumor Board (MCC MTB).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited States
Collaborators--

Timeline

Phase 2Recruiting
20172018201920202021202220232024202520262027
First PostedMar 24, 2017
Enrollment StartApr 11, 2017
Primary CompletionApr 1, 2027
TodayJul 2, 2026
Enrollment to primary: 10.0 yearsPosted 9.3 years agoPrimary completion in 9 months

Interventions

Therapeutic Interventiondrug

Therapeutic Intervention